Background Tenofovir (TDF) and entecavir (ETV) are first-line treatments for patients with
chronic hepatitis B virus (HBV) infection. However, the effect of TDF versus ETV on the …

Background: Hepatitis B, often leading to Hepatocellular carcinoma (HCC), poses a major
global health challenge. While Tenofovir (TDF) and Entecavir (ETV) are potent treatments …

Background Entecavir (ETV) and tenofovir disoproxil fumarate (TDF) are recommended as
first-line choices regarding the treatment of chronic hepatits B. The impact of the two antiviral …

Background Tenofovir (TDF) and entecavir (ETV) are highly effective and well-tolerated
nucleos (t) ide analogs commonly prescribed for hepatitis B virus (HBV) treatment. Yet, it is …

Purpose: Tenofovir (TDF) and entecavir (ETV) are both equally recommended as first-line
treatments for patients with chronic hepatitis B (CHB). They have comparable efficacy in …

Background and Aims Whether tenofovir or entecavir has different effects on the prevention
of hepatitis B virus (HBV)–related hepatocellular carcinoma (HCC) in secondary and tertiary …

Background There is still controversy about whether tenofovir disoproxil fumarate (TDF) and
entecavir (ETV) have different effects on the outcomes of patients with hepatitis B virus …

Entecavir (ETV) and Tenofovir disoproxil fumarate (TDF) are the first‐line drugs for the
treatment of chronic hepatitis B virus (HBV). However, the impact of these two antiviral …

Background and Aims Studies have suggested that tenofovir disoproxil fumarate (TDF)
treatment is associated with a significantly lower risk of hepatocellular carcinoma (HCC) …

Background Tenofovir disoproxil fumarate (TDF) and entecavir (ETV) reduce the risk of
hepatocellular carcinoma (HCC) in patients of hepatitis B. This study compared the …